856 Revised Classification of Low Grade Dysplasia (LGD) in Barrett's Esophagus (BE): Time to Rethink the Role of LGD As a Risk Stratification Strategy in BE

2014 ◽  
Vol 146 (5) ◽  
pp. S-147 ◽  
Author(s):  
Prashanth Vennalaganti ◽  
Vijay Kanakadandi ◽  
John R. Goldblum ◽  
Deepa T. Patil ◽  
Sharad C. Mathur ◽  
...  
2019 ◽  
Vol 156 (6) ◽  
pp. S-249
Author(s):  
Allon Kahn ◽  
Amrit Kamboj ◽  
Prasad G. Iyer ◽  
Kenneth K. Wang ◽  
Cadman L. Leggett

2021 ◽  
Vol 1 (1) ◽  
pp. 41-47
Author(s):  
Vani J.A. Konda ◽  
Ashton Ellison

Challenges remain to determine which patients with Barrett’s esophagus with no dysplasia or low-grade dysplasia would benefit from therapy or tailored surveillance intervals. Biomarkers have the potential to improve risk stratification in Barrett’s esophagus through predictive capability and ease of use. We highlight biomarkers investigated in risk stratification in Barrett’s esophagus including p53 aberrancy, chromosomal derangements, immunofluorescence-based panels, and DNA methylation panels. We explore non-endoscopic approaches that may be implemented in the office-based setting and discuss the utility of sample collection in patients with Barrett’s esophagus and in the broader population.


2018 ◽  
Vol 88 (5) ◽  
pp. 807-815.e2 ◽  
Author(s):  
Jon M. Davison ◽  
Maulin B. Shah ◽  
Christopher Deitrick ◽  
Jennifer Chennat ◽  
Ken E. Fasanella ◽  
...  

2015 ◽  
Vol 13 (3) ◽  
pp. 459-465.e1 ◽  
Author(s):  
Prashanthi N. Thota ◽  
Hyun-Ju Lee ◽  
John R. Goldblum ◽  
Xiuli Liu ◽  
Madhusudhan R. Sanaka ◽  
...  

2021 ◽  
Author(s):  
EA Nieuwenhuis ◽  
SN van Munster ◽  
BLAM Weusten ◽  
L Alvarez Herrero ◽  
A Bogte ◽  
...  

2015 ◽  
Vol 61 (1) ◽  
pp. 158-167 ◽  
Author(s):  
Kavel Visrodia ◽  
Prasad G. Iyer ◽  
Cathy D. Schleck ◽  
Alan R. Zinsmeister ◽  
David A. Katzka

Sign in / Sign up

Export Citation Format

Share Document